Natural History Study of Retinitis Pigmentosa Type 11

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04805658

Acronym

ReSa

Enrollment

Registered

2021-03-18

Start date

2021-02-01

Completion date

2028-04-01

Last updated

2025-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinitis Pigmentosa 11, Retinitis Pigmentosa

Keywords

Retinitis, RP, PRPF31

Brief summary

Observational study of patients with retinitis pigmentosa type 11

Detailed description

Natural history study with clinical examination every 6 months.

Interventions

DIAGNOSTIC_TESTClinical examinations

Clinical examinations

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of retinitis pigmentosa caused by a disease-causing mutation involving the PRPF31 gene * Or disease-causing mutation involving the PRPF31 gene without the clinical diagnosis of retinitis pigmentosa

Exclusion criteria

* Under 18 years * Other types of retinitis pigmentosa

Design outcomes

Primary

Measure	Time frame	Description
Progression of disease	24 mounths	Retinal function measured by functional and structural testing

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026